NEW YORK ( TheStreet) -- MannKind Corporation (Nasdaq: MNKD) hit a new 52-week low Monday as it is currently trading at $2.11, below its previous 52-week low of $2.14 with 296,254 shares traded as of 10:19 a.m. ET. Average volume has been 2.4 million shares over the past 30 days. MannKind has a market cap of $378.5 million and is part of the health care sector and drugs industry. Shares are down 13.6% year to date as of the close of trading on Friday. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States, Europe, and Asia.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter